Minerva Neurosciences | NERV - Batas Pemasukan





Batas Pemasukan Perubahan Tanggal
Acadia Pharmaceuticals USD 31.5M 27.86M 2026-06
Adma Biologics USD 45.33M 4.05M 2026-03
ALKERMES USD 501K 66.98M 2026-06
Alterity Therapeutics Limited AUD -6.3M 525.41K 2025-12
AstraZeneca USD 2.51B 573M 2026-06
BioCryst Pharmaceuticals USD 78.4M 167.45M 2026-06
Bristol-Myers Squibb USD 3.32B 640M 2026-06
Cipla INR 7.89B 2.34B 2026-06
Clal Biotechnology ILS -6.17M 15.56M 2022-12
Compugen USD -7.67M 64.51M 2026-03
CSL USD 401M 96.5M 2025-12
Eli Lilly USD 7.1B 301M 2026-06
GlaxoSmithKline GBP 435M 1.3B 2026-06
Grifols EUR 114.37M 34.03M 2025-12
Halozyme Therapeutics USD 229.91M 79.86M 2026-06
Ionis Pharmaceuticals USD -114.65M 21.65M 2026-06
J&J USD 5.53B 299M 2026-06
Merck USD -1.34B 2.9B 2026-06
Minerva Neurosciences USD 1.44M 21.07M 2024-12
Neurocrine Biosciences USD 144.4M 53.5M 2026-06
Novartis USD 3.26B 108M 2026-06
Novavax USD 17.53M 219.91M 2025-12
Pfizer USD -248M 2.94B 2026-06
Roche Holding CHF 6.87B 1.4B 2026-06
Sanofi EUR 343M 1.27B 2026-06
Takeda JPY 113.2B 137.52B 2026-06
Vanda Pharmaceuticals USD -18.9M 13.58M 2024-12